NuntioBot

NuntioBot launches beta of the Mosquito Scanner, first in the line of the next few additional scanners. Hop onto NuntioFM to get a quick breakdown in 10 minutes:

$ENTX 08:45 on Apr. 02 2026 Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds

$QNTM 08:30 on Apr. 02 2026 Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

$INBS 08:30 on Apr. 02 2026 Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

$BBBY PR during News Halt on Apr. 02 2026 Letter to Shareholders from Marcus Lemonis, Executive Chairman and CEO: The Growth Phase

$MOBX 08:00 on Apr. 02 2026 Mobix Labs Expands Presence Inside F-22 Raptor with 5X Order Surge for Mission-Critical Aircraft Systems

$LPCN PR during News Halt on Apr. 02 2026 Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression

$VTAK 08:00 on Apr. 02 2026 Catheter Precision Engages Strategic Advisor

$TKLF 08:00 on Apr. 02 2026 Tokyo Lifestyle Secures US$2.56 Million Investment from Private Strategic Investor to Strengthen Operations and Expansion in Hong Kong

$RCAT 07:58 on Apr. 02 2026 Red Cat Secures New Orders for Black Widow™ Drones from NATO Ally

$ROLR 08:00 on Apr. 02 2026 High Roller Technologies Regains Compliance with NYSE American Continued Listing Standards

$AUID 08:00 on Apr. 02 2026 authID Announces Strategic Partnership with Formula5 to Deliver Biometric Identity Security for Microsoft-First Enterprises

$COCP 08:00 on Apr. 02 2026 Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

$SNGX 07:30 on Apr. 02 2026 Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

$CNTX 07:30 on Apr. 02 2026 Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

$PSTV PR during News Halt on Apr. 02 2026 Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

$UCAR 07:00 on Apr. 02 2026 U POWER LIMITED Makes Major Breakthrough in Thailand's Heavy-Duty Truck Battery-Swapping Market

$SKYQ 07:00 on Apr. 02 2026 Sky Quarry's Nevada Refinery Gains Strategic Value as Brent Crude Surpasses $110 and West Coast Refining Capacity Shrinks

$GPUS 06:00 on Apr. 02 2026 Hyperscale Data Receives $26.6 Million of Cash Related to Litigation Settlement; Cash Receipt Represents a Significant Liquidity Event for the Company

$MLGO 09:00 on Apr. 01 2026 MicroAlgo Announces Substantial Increase of 143.5% in Net Profit for 2025

$XAIR 09:00 on Apr. 01 2026 Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)